| 1. |
Tranexamic acid |
1197-18-8 |
|
- Developed completely novel
and scalable technology with
high throughput and total
back integration. Currently
conducting 25 to 75 kg pilot
scale trials.
|
| 2. |
Phenylephrine |
61-76-7 |
|
- Developed completely novel
technology with total back
integration and significant
reduction in raw material
cost. Currently conducting 25
to 75 kg pilot scale trials.
|
| 3. |
Moxifloxacin (R,
R)-Nonane |
151213-42-2 |
|
- Developed a novel technology
with high throughout and
significant reduction in raw
material cost. Currently
conducting 15 to 50 kg pilot
scale trials.
|
| 4. |
2,4-Xylenol |
105-67-9 |
|
- Novel selective technology
developed to yield high purity
product used for special
applications. Currently
conducting 50 to 200 kg pilot
scale trials.
|
| 5. |
2,5-Xylenol |
95-87-4 |
|
- Novel selective technology
developed to yield high purity
product used for special
applications. Currently
conducting 50 to 200 kg pilot
scale trials.
|
| 6. |
2,4/2,5-tris
xylenol
phosphate |
25155-23-1 |
|
- Currently conducting 50 to
200 kg pilot scale trials.
|
| 7. |
Amyl-m-cresol |
1300-94-3 |
|
- Novel technology developed
for green synthesis of the
product. 1 to 5 kg pilot trials
are in progress.
|
